Signal Peptide-independent Secretion of Keratin-19 by Pancreatic Cancer Cells

Overview

Journal bioRxiv

Date 2025 Feb 3

PMID 39896665

Authors

Philip Moresco

Jonathan P Kastan

Jung-In Yang

Rishvanth Prabakar

Francesca Minicozzi

Dexter W Adams

Paolo Cifani

David A Tuveson

Douglas T Fearon

Affiliations

Soon will be listed here.

Abstract

The exclusion of T cells causes immune escape of pancreatic ductal adenocarcinoma (PDA). T cell exclusion is mediated by the interaction between CXCR4 on T cells and its ligand, CXCL12, which is complexed to keratin-19 (KRT19) on the surface of PDA cells. KRT19 secretion by PDA cells is essential to this process but is unusual because KRT19 lacks an endoplasmic reticulum (ER)-directing signal peptide (SP). By using biotinylation by an ER-restricted TurboID system and a split-GFP assay in PDA cells, we demonstrate that KRT19 enters the ER via its "head" domain. Additionally, KRT19 is shown to interact with the signal recognition particle and its secretion is sensitive to canonical protein secretion inhibitors. In vivo, mouse tumors formed with ER-TurboID-expressing PDA cells contain biotinylated KRT19. In contrast, keratin-8 (KRT8), which colocalizes with KRT19 on the surface of PDA cells, does not enter the ER. Rather, KRT8 is externalized via secretory autophagy possibly in a complex with KRT19. Thus, despite lacking a classical SP, PDA cells secrete KRT19 to capture CXCL12 and protect against immune attack.

References

Song W, Raden D, Mandon E, Gilmore R . Role of Sec61alpha in the regulated transfer of the ribosome-nascent chain complex from the signal recognition particle to the translocation channel. Cell. 2000; 100(3):333-43. DOI: 10.1016/s0092-8674(00)80669-8. View

Wang Z, Moresco P, Yan R, Li J, Gao Y, Biasci D . Carcinomas assemble a filamentous CXCL12-keratin-19 coating that suppresses T cell-mediated immune attack. Proc Natl Acad Sci U S A. 2022; 119(4). PMC: 8794816. DOI: 10.1073/pnas.2119463119. View

Feig C, Jones J, Kraman M, Wells R, Deonarine A, Chan D . Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. Proc Natl Acad Sci U S A. 2013; 110(50):20212-7. PMC: 3864274. DOI: 10.1073/pnas.1320318110. View

Hingorani S, Wang L, Multani A, Combs C, Deramaudt T, Hruban R . Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell. 2005; 7(5):469-83. DOI: 10.1016/j.ccr.2005.04.023. View

Fujita N, Hayashi-Nishino M, Fukumoto H, Omori H, Yamamoto A, Noda T . An Atg4B mutant hampers the lipidation of LC3 paralogues and causes defects in autophagosome closure. Mol Biol Cell. 2008; 19(11):4651-9. PMC: 2575160. DOI: 10.1091/mbc.e08-03-0312. View

Zheng Q, Chen Y, Chen D, Zhao H, Feng Y, Meng Q . Calcium transients on the ER surface trigger liquid-liquid phase separation of FIP200 to specify autophagosome initiation sites. Cell. 2022; 185(22):4082-4098.e22. DOI: 10.1016/j.cell.2022.09.001. View

Merrill J, Inguscio A, Chung T, Demestichas B, Garcia L, Habel J . Sensitive, non-immunogenic imaging of cancer metastases and immunotherapy response. Cell Stress. 2023; 7(8):59-68. PMC: 10468692. DOI: 10.15698/cst2023.08.288. View

Walter P, Lingappa V . Mechanism of protein translocation across the endoplasmic reticulum membrane. Annu Rev Cell Biol. 1986; 2:499-516. DOI: 10.1146/annurev.cb.02.110186.002435. View

Schafer T, Zentgraf H, Zehe C, Brugger B, Bernhagen J, Nickel W . Unconventional secretion of fibroblast growth factor 2 is mediated by direct translocation across the plasma membrane of mammalian cells. J Biol Chem. 2003; 279(8):6244-51. DOI: 10.1074/jbc.M310500200. View

10.

Yan R, Moresco P, Gegenhuber B, Fearon D . T cell-mediated development of stromal fibroblasts with an immune-enhancing chemokine profile. Cancer Immunol Res. 2023; . DOI: 10.1158/2326-6066.CIR-22-0593. View

11.

Bockorny B, Grossman J, Hidalgo M . Facts and Hopes in Immunotherapy of Pancreatic Cancer. Clin Cancer Res. 2022; 28(21):4606-4617. DOI: 10.1158/1078-0432.CCR-21-3452. View

12.

Rabouille C . Pathways of Unconventional Protein Secretion. Trends Cell Biol. 2016; 27(3):230-240. DOI: 10.1016/j.tcb.2016.11.007. View

13.

Kim D, Shin J, Lee J, Kim H, Chung S, Yoo H . A selective ER-phagy exerts neuroprotective effects via modulation of α-synuclein clearance in parkinsonian models. Proc Natl Acad Sci U S A. 2023; 120(37):e2221929120. PMC: 10500278. DOI: 10.1073/pnas.2221929120. View

14.

von Heijne G . Signal sequences. The limits of variation. J Mol Biol. 1985; 184(1):99-105. DOI: 10.1016/0022-2836(85)90046-4. View

15.

Jagannathan S, Nwosu C, Nicchitta C . Analyzing mRNA localization to the endoplasmic reticulum via cell fractionation. Methods Mol Biol. 2011; 714:301-21. PMC: 3718476. DOI: 10.1007/978-1-61779-005-8_19. View

16.

Biasci D, Smoragiewicz M, Connell C, Wang Z, Gao Y, Thaventhiran J . CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response. Proc Natl Acad Sci U S A. 2020; 117(46):28960-28970. PMC: 7682333. DOI: 10.1073/pnas.2013644117. View

17.

Nagai K, Oubridge C, Kuglstatter A, Menichelli E, Isel C, Jovine L . Structure, function and evolution of the signal recognition particle. EMBO J. 2003; 22(14):3479-85. PMC: 165607. DOI: 10.1093/emboj/cdg337. View

18.

Linxweiler M, Schick B, Zimmermann R . Let's talk about Secs: Sec61, Sec62 and Sec63 in signal transduction, oncology and personalized medicine. Signal Transduct Target Ther. 2017; 2:17002. PMC: 5661625. DOI: 10.1038/sigtrans.2017.2. View

19.

Cross B, McKibbin C, Callan A, Roboti P, Piacenti M, Rabu C . Eeyarestatin I inhibits Sec61-mediated protein translocation at the endoplasmic reticulum. J Cell Sci. 2009; 122(Pt 23):4393-400. PMC: 2779136. DOI: 10.1242/jcs.054494. View

20.

Lang S, Pfeffer S, Lee P, Cavalie A, Helms V, Forster F . An Update on Sec61 Channel Functions, Mechanisms, and Related Diseases. Front Physiol. 2017; 8:887. PMC: 5672155. DOI: 10.3389/fphys.2017.00887. View